Home > Insider Trading > Filing (0001140361-13-024277)

Filing Details

Accession Number:: 0001140361-13-024277
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-06-05 17:46:11
Reporting Period:: 2013-05-23

Filing Date:: 2013-06-05
Accepted Time:: 2013-06-05 17:46:11
Original Submission Date:: 2013-06-04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1196298	Nephros Inc	NEPH	Surgical & Medical Instruments & Apparatus (3841)	133971809

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1001391	E Charles Davidson	C/O Wexford Capital Lp 411 West Putnam Ave. Greenwich CT 06830	No	No	Yes	No
1048462	Wexford Capital Lp	411 West Putnam Avenue Suite 125 Greenwich CT 06830	No	No	Yes	No
1048485	Joseph Jacobs	C/O Wexford Capital Lp 411 West Putnam Avenue, Suite 125 Greenwich CT 06830	No	No	Yes	No
1413621	Lambda Investors Llc	411 West Putnam Avenue Suite 125 Greenwich CT 06830	No	No	Yes	No
1472112	Wexford Gp Llc	C/O Wexford Capital Lp Suite 125 Greenwich CT 06830	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Acquisiton	2013-05-23	2,992,884	$0.00	6,721,676	No	4	P	Indirect	Held directly by Lambda Investors LLC
Common Stock, Par Value $0.001	Acquisiton	2013-05-23	46,692	$0.00	46,692	No	4	A	Indirect	Held directly by Wexford Capital LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Held directly by Lambda Investors LLC
No	4	A	Indirect	Held directly by Wexford Capital LP

Footnotes

On May 23, 2013, Lambda Investors LLC ('Lambda") purchased, pursuant to a rights offering with Nephros, Inc. (the "Company"), 2,992,884 shares of Common Stock at a purchase price of $0.60 per share for a cost of $1,795,730.40.
On May 23, 2013, the Company granted each of Mr. Arthur Amron and Dr. Paul Mieyal, 23,346 restricted shares of Common Stock (the "Restricted Stock") in respect of their service as members of the Board of Directors of the Company. At the request of Mr. Amron and Dr. Mieyal, the Restricted Stock was granted to Wexford Capital LP.
This form is jointly filed by Lambda, Wexford Capital LP ("Wexford"), Charles E. Davidson ("Davidson"), Joseph M. Jacobs ("Jacobs") and Wexford GP LLC ("Wexford GP"). The reported securities are held directly by Lambda and by Wexford. Wexford serves as manager, investment advisor or sub-advisor of Lambda, and as such may be deemed to share beneficial ownership of the securities beneficially owned by Lambda, but disclaims such beneficial ownership to the extent such beneficial ownership exceeds its pecuniary interest. Wexford GP, as the general partner of Wexford, may be deemed to share beneficial ownership of the securities beneficially owned by Lambda, but disclaims such ownership to the extent such beneficial ownership exceeds its pecuniary interest. (continued under Footnote (4) below).
(continued from Footnote (3) above) Messrs. Davidson and Jacobs, as the controlling persons of Wexford GP, may be deemed to share beneficial ownership of any securities beneficially owned by Lambda for which Wexford serves as manager, investment advisor or sub-advisor, but disclaim such beneficial ownership to the extent such beneficial ownership exceeds their pecuniary interest.